Gwajin asibiti na kwayar cutar kwayar cutar COVID-19 ta fara a cikin Isra'ila

• Gwajin gwaji na asibiti akan 24 masu aikin sa kai marasa magani don kwafin kwafin kwaya daya wanda aka yarda dashi.
• Ana iya amfani da kwantena a matsayin mai ƙarfafawa akan mafi saurin yaduwar Delta.
• Kwayar ta yi gwajin a kan aladu kuma dabbobin sun samar da kwayoyin cuta bayan an sha su.

Urushalima Oramed Magunguna ya sanar da cewa an samu izini daga Cibiyar Kiwon Lafiya ta Tel Aviv Sourasky don fara gwajin asibiti a kan masu aikin sa kai 24 da ba a yi wa allurar rigakafi ba don kwaya guda ta kwayar COVID-19. 

Kamfanin Oramed ya sanar a watan Maris cewa ya gwada kwayarsa a kan aladu kuma dabbobin sun samar da kwayoyi bayan an sarrafa su.

Wani nau'in kwaya na rigakafin coronavirus na iya zama "mai canza wasa" a cikin ƙasashe masu ƙarancin allurar rigakafi, in ji mai haɓaka.

Kamfanin wanda ya kware a kirkirar nau'ikan magungunan baka wanda yawanci ana yin su ta hanyar allura, shima a halin yanzu yana gudanar da gwaji don maganin kanshi na insulin na bakin don magance ciwon-suga na Type-2. Dukkanin allurar rigakafin COVID-19 data kasance a halin yanzu ana sarrafa su ta hanyar allura ɗaya ko biyu.

A cewar Shugaban kamfanin Oramed Nadav Kidron, ana sa ran fara gwajin kwayar ta COVID-19 a watan gobe, da zarar ta samu amincewar karshe daga Ma’aikatar Kiwon Lafiya.

Kidron ya kara da cewa za a iya amfani da kwayar a matsayin kara karfin gwiwa kan karin nau'in Delta mai saurin yaduwa.

Kidron ya ce "Alurar rigakafinmu ta baka, wacce ba ta dogara da sarkar daskarewa ba kamar sauran allurar rigakafin coronavirus ba, na iya nufin duk wani bambanci tsakanin wata kasa da za ta iya fita daga cutar ko kuma a'a," in ji Kidron.